Jau‐Shyong Hong

Active 1976–2025

162
Papers
35,656
Citations
100
h-index
160
i10-index

Citations

Citations per year for Jau‐Shyong Hong1967: 1 citations1977: 18 citations1978: 43 citations1979: 49 citations1980: 68 citations1981: 49 citations1982: 33 citations1983: 55 citations1984: 24 citations1985: 24 citations1986: 43 citations1987: 37 citations1988: 32 citations1989: 22 citations1990: 61 citations1991: 40 citations1992: 36 citations1993: 22 citations1994: 51 citations1995: 43 citations1996: 50 citations1997: 37 citations1998: 25 citations1999: 44 citations2000: 53 citations2001: 43 citations2002: 99 citations2003: 180 citations2004: 264 citations2005: 326 citations2006: 320 citations2007: 417 citations2008: 519 citations2009: 451 citations2010: 518 citations2011: 585 citations2012: 641 citations2013: 481 citations2014: 519 citations2015: 522 citations2016: 422 citations2017: 434 citations2018: 414 citations2019: 1,105 citations2020: 1,199 citations2021: 1,130 citations2022: 886 citations2023: 611 citations2024: 795 citations2025: 436 citations2026: 7 citations1968–1976: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,484 citing papers, 26.6% of this breakdownChina: 1,844 citing papers, 14.1% of this breakdownItaly: 612 citing papers, 4.7% of this breakdownUnited Kingdom: 608 citing papers, 4.6% of this breakdownGermany: 550 citing papers, 4.2% of this breakdownSouth Korea: 539 citing papers, 4.1% of this breakdownCanada: 450 citing papers, 3.4% of this breakdownIndia: 376 citing papers, 2.9% of this breakdownAustralia: 322 citing papers, 2.4% of this breakdownJapan: 322 citing papers, 2.4% of this breakdownSpain: 313 citing papers, 2.4% of this breakdownFrance: 285 citing papers, 2.2% of this breakdown
0%26.6%Other 26%

Fields

  • Neuroscience40.1%
  • Medicine34.4%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Immunology and Microbiology2.8%
  • Environmental Science2%
  • Agricultural and Biological Sciences1.2%
  • Other4%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms13.4%
  • Parkinson's Disease Mechanisms and Treatments5.4%
  • Alzheimer's disease research and treatments4.1%
  • Tryptophan and brain disorders3.9%
  • Neuroscience and Neuropharmacology Research2.8%
  • Nerve injury and regeneration2%
  • Other68.4%

Coauthors

All papers

Open in search
  1. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

    Authors: , , - Nature reviews. Neuroscience 2006 cited by 4,108

  2. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

    Authors: , , , , , , , - Glia 2007 cited by 2,157

  3. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism

    Authors: , - Progress in Neurobiology 2005 cited by 1,549

  4. Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

    Authors: , , , , , , , , , , - The FASEB Journal 2005 cited by 1,283

  5. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model

    Authors: , , , , , , , , , - Journal of Neuroinflammation 2021 cited by 210

  6. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression

    Authors: , - Trends in Immunology 2008 cited by 809

  7. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration

    Authors: , , , , , - Journal of Neuroinflammation 2019 cited by 142

  8. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , - Neurotoxicity Research 2009 cited by 257

  9. Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegeneration

    Authors: , , , , , - Free Radical Biology and Medicine 2023 cited by 54

  10. Role of oxidative stress in epileptic seizures

    Authors: , , , , , , , , - Neurochemistry International 2011 cited by 422

  11. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

    Authors: , , , , , , , , , , , , , - The International Journal of Neuropsychopharmacology 2008 cited by 312

  12. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

    Authors: , , , - Glia 2013 cited by 269

  13. A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration

    Authors: , , , , , , , , , , - Journal of Neuroinflammation 2020 cited by 107

  14. Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

    Authors: , , , , , - Environmental Health Perspectives 2011 cited by 369

  15. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

    Authors: , - Journal of Pharmacology and Experimental Therapeutics 2003 cited by 1,097

  16. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment

    Authors: , , , , , - Journal of Neuroinflammation 2008 cited by 528

  17. Chronic microglial activation and progressive dopaminergic neurotoxicity

    Authors: , - Biochemical Society Transactions 2007 cited by 319

  18. Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

    Authors: , , , , , - Journal of Neuroscience 2000 cited by 879

  19. Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease

    Authors: , , , , , - Journal of Neurochemistry 2002 cited by 688

  20. Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration

    Authors: , , , , , , , , , , , , , - Molecular Neurobiology 2013 cited by 92

  21. Microglial Nox2 Plays a Key Role in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

    Authors: , , , , , , , , , , - Frontiers in Immunology 2021 cited by 42

  22. Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway

    Authors: , , , , , , , , - Molecular Neurobiology 2023 cited by 37

  23. HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration

    Authors: , , , , , - Journal of Neuroscience 2011 cited by 363

  24. Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action

    Authors: , , , , , - Journal of Pharmacology and Experimental Therapeutics 2007 cited by 563